Achieving global impact in effective healthcare & sustainable agriculture by helping talented entrepreneurs / scientist set up exceptional companies.
Investment Type: Venture Capital
Investment Stage: Series B
Portfolio 20
| Date | Name | Website | Total Raised | Location |
| 11.05.2024 | Flindr | flindrtx.com | - | - |
| 12.10.2022 | SibyllaBio... | sibyllabiotech.it | $23M | Italy, Ven... |
| 31.08.2022 | AstriVax | astrivax.com | $32.62M | Belgium, F... |
| 06.06.2022 | Dualyx | dualyx.com | $43.75M | - |
| 31.12.2021 | Corteria P... | corteriapharma.com | $69.6M | France, Il... |
| 10.03.2021 | Agomab The... | agomab.com | $312.25M | Belgium, E... |
| - | Coave Ther... | coavetx.com | $38.84M | France, Il... |
| - | Confo Ther... | confotherapeutics.com | $40.74M | Belgium |
| - | Oxular | oxular.com | $37M | United Kin... |
| - | Animab | animab.com | - | - |
Show more
Mentions in press and media 8
| Date | Title | Description |
| 10.07.2024 | Augustine Therapeutics: €17 Million Raised For Developing Neurodegenerative And Cardiometabolic Disease Treatments | Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, announced that it has raised €17 million in the first closing of its Series A round. This funding round was... |
| 27.05.2024 | French biotech startup Biodol Therapeutics secures €7M to treat chronic pain: Know more | Read this article in: Montarnaud-based Biodol Therapeutics, a French biotech company developing next-generation pain treatments, announced on Tuesday, May 21, that it has been awarded €7M by BPI France through the i-DEMO call for projects. ... |
| 25.04.2024 | Dutch-based Flindr Therapeutics secures €20M to discover and develop precision oncology therapeutics | Read this article in: Netherlands-based Flindr Therapeutics, a company focused on precision cancer treatments, announced that it has secured €20M in a Series A round of funding. This funding will help advance the Dutch company’s cancer trea... |
| 06.12.2023 | Tanai Therapeutics raises € 2.85 million round in Seed funding | Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a new spin-off company based on research at the VIB-UGent Center for Inflammation Research. With an initial see... |
| 16.08.2023 | ‘Boil the weed inside out’: RootWave launches high-frequency, ‘regen ag-friendly’ weed zapper for orchards | Growers may differ on their methods of weed management, but most would agree outsmarting those weeds is one of the toughest tasks in the business for organic farmers and conventional row croppers alike. Chemicals such as Glyphosate were sup... |
| 01.04.2022 | V-Bio Ventures Closes Second Fund, at EUR 110M | V-Bio Team V-Bio Ventures, a Ghent, Belgium-based independent venture capital firm focused on biotech, closed its second fund, V-Bio Fund 2, at EUR 110m. Almost all limited partners of their first fund are participating in this second fund,... |
| 24.11.2020 | With companies like Aphea Bio & Biotalys, Ghent is Europe’s hidden gem for ag biotech | The Belgian city of Ghent owes its medieval splendor to being in the middle of the sheep-filled pastureland of Flanders. In centuries past, this provided plentiful supplies of wool – just as breakthrough textiles technologies took off acros... |
| 22.01.2020 | Zap! This UK startup just raised €6.5m to commit electricide on weeds | RootWave, a UK startup developing ways to kill weeds with ever more precise zaps of electricity, has raised a €6.5 million ($7.2 million) Series A investment round. V-Bio Ventures and the Rabo Food & Agri Innovation Fund led the round, ... |